Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitor in intermediate-stage HCC exceeding the up-to-7 criteria: A retrospective cohort study.
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Miao Xue, Yanqin Wu, Wenzhe Fan, Jiaping Li
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410814320